Catheter Ablation Plus LAAO Versus Anticoagulation in Frail Elderly Patients With Atrial Fibrillation
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 200 participants.
Also called NCT07441382
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 200 participants
- Registry
-
NCT07441382
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT07441382. Randomized; no masking; primary purpose treatment. Start 2026-03-24 (actual); primary completion 2027-05-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Catheter Ablation Plus LAAO Versus Anticoagulation in Frail Elderly Patients With Atrial Fibrillation
- Acronym
- CLEAR-AF
- Condition
- Atrial Fibrillation (AF)
- Condition
- Stroke
- Condition
- Hemorrhage
- Condition
- Frailty
- Condition
- Atrial Appendage
- Condition
- Catheter Ablation
- Condition
- Anticoagulants
- Intervention (Device)
- catheter ablation combined with LAAO (Left Atrial Appendage Occlusion)
- Intervention (Drug)
- Atrial Fibrillation Radiofrequency Ablation Only
- Lead sponsor
- Guangdong Provincial People's Hospital
- Collaborator
- Abbott (China)
Record details
- Record id
cardio:ct-nct07441382- Content hash
5a2f0be3e6177d41444bc6d9bfa767853d7c3c89549b470b928035e9e49aa70b